Skip to main content
KOMIPHARM INTERNATIONAL CO., LTD. logo

KOMIPHARM INTERNATIONAL CO., LTD. — Investor Relations & Filings

Ticker · 041960 ISIN · KR7041960006 KO Manufacturing
Open in API
Filings indexed 326 across all filing types
Latest filing 2022-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 041960

About KOMIPHARM INTERNATIONAL CO., LTD.

https://komipharm.co.kr/en/

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for the company Komipharm. It details the outcomes of various agenda items, including the approval of financial statements, board member appointments, and dividend resolutions. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an existing outside director and the appointment of a new one at Komipharm. This falls under the category of board and management changes.
2022-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It provides the auditor's opinion (적정 - unqualified), financial highlights, and key accounting data for the fiscal year. While it contains financial data, it is a specific regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report/Information document. FY 2021
2022-03-16 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'KomiPharm' (주식회사 코미팜) for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the comprehensive management discussion and analysis (MD&A) and business overview typical of a full 10-K, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2021
2022-03-16 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Komipharm, which includes detailed agenda items, board member nominations, financial statements, and voting procedures. It is a formal proxy statement and meeting notice sent to shareholders to solicit votes for the upcoming Annual General Meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-11 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and is a formal filing submitted to the Financial Supervisory Service (FSS) in South Korea. It contains details regarding the upcoming Annual General Meeting (AGM), including agenda items (approval of financial statements, election of directors and auditors), proxy solicitation information, and voting procedures. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2022-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.